Skyline Medical Inc. (NASDAQ:SKLN) Files An 8-K Other Events
Item 8.01. Other Events.
On December 29, 2016, Skyline Medical Inc. (the Company) issued a
press release announcing the decision of the Nasdaq Hearings
Panel to grant the Company an extension through April 11, 2017 to
evidence compliance with the $2.5 million stockholders equity
requirement of the continued listed standards of The Nasdaq
Capital Market. A copy of the press release is furnished as
Exhibit 99.1 to this report.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description/Exhibit |
| 99.1 | Press Release of Skyline Medical Inc. dated December 29, 2016 |
About Skyline Medical Inc. (NASDAQ:SKLN)
Skyline Medical Inc. is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed. The Company also manufactures and sells two disposable products required for system operation: a bifurcated single procedure filter and tissue trap, and a single use bottle of cleaning solution. Both items are used on a single procedure basis. Its STREAMWAY Automated Surgical Fluid Waste Management System (FMS) is a wall mounted automated system that disposes of an unlimited amount of suctioned fluid from the patient using standard surgical tubing. The FMS suctions surgical waste fluid from the patient using standard surgical tubing. Skyline Medical Inc. (NASDAQ:SKLN) Recent Trading Information
Skyline Medical Inc. (NASDAQ:SKLN) closed its last trading session up +0.01 at 2.85 with 265,516 shares trading hands.
